Journal of Gastroenterology

, Volume 42, Issue 4, pp 267–274

Metabolic syndrome and gastrointestinal diseases

  • Sumio Watanabe
  • Mariko Hojo
  • Akihito Nagahara
Review

Abstract

Metabolic syndrome is a cluster of metabolic abnormalities consisting essentially of obesity, especially abdominal obesity. Metabolic syndrome has been highlighted as a risk factor for cardiovascular and other chronic diseases. Obesity has been implicated in various gastrointestinal diseases such as gastroesophageal reflux diseases and colorectal cancer. Recently, abdominal obesity has been shown to be more important than obesity as expressed by an elevated body mass index as a causative factor for the development of these diseases. In addition to the mechanical effects of obesity, such as an increase in intra-abdominal pressure from large amounts of adipose tissue, substances that adipose tissues secrete, such as tumor necrosis factor-α, interleukin-6, leptin, and insulin-like growth factor-1, have been proposed to be pathogenic links to these diseases. In this review, we discuss the association of metabolic syndrome or the individual components of metabolic syndrome, focusing on obesity and abdominal obesity, with gastrointestinal diseases.

Key words

visceral obesity adipokines GERD esophageal adenocarcinoma colorectal cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Expert Panel on Detection2001Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA285248697CrossRefGoogle Scholar
  2. 2.
    Schneider, HJ, Glaesmer, H, Klotsche, J, Bohler, S, Lehnert, H, Zeiher, AM,  et al. 2007Accuracy of anthropometric indicators of obesity to predict cardiovascular riskJ Clin Endocrinol Metab9258994PubMedCrossRefGoogle Scholar
  3. 3.
    Locke, GR,3rd, Talley, NJ, Fett, SL, Zinsmeister, AR, Melton, LJ,3rd 1997Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, MinnesotaGastroenterology112144856PubMedCrossRefGoogle Scholar
  4. 4.
    Flegal, KM, Carroll, MD, Ogden, CL, Johnson, CL 2002Prevalence and trends in obesity among US adults, 1999–2000JAMA28817237PubMedCrossRefGoogle Scholar
  5. 5.
    Murray, L, Johnston, B, Lane, A, Harvey, I, Donovan, J, Nair, P,  et al. 2003Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter ProjectInt J Epidemiol3264550PubMedCrossRefGoogle Scholar
  6. 6.
    Locke, GR,3rd, Talley, NJ, Fett, SL, Zinsmeister, AR, Melton, LJ,3rd 1999Risk factors associated with symptoms of gastroesophageal refluxAm J Med1066429PubMedCrossRefGoogle Scholar
  7. 7.
    Nandurkar, S, Locke, GR,3rd, Fett, S, Zinsmeister, AR, Cameron, AJ, Talley, NJ 2004Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a communityAliment Pharmacol Ther20497505PubMedCrossRefGoogle Scholar
  8. 8.
    Wajed, SA, Streets, CG, Bremner, CG, DeMeester, TR 2001Elevated body mass disrupts the barrier to gastroesophageal refluxArch Surg13610148discussion 1018–9PubMedCrossRefGoogle Scholar
  9. 9.
    Clements, RH, Gonzalez, QH, Foster, A, Richards, WO, McDowell, J, Bondora, A,  et al. 2003Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypassObes Surg136104PubMedCrossRefGoogle Scholar
  10. 10.
    Ruhl, CE, Everhart, JE 1999Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination SurveyAnn Epidemiol942435PubMedCrossRefGoogle Scholar
  11. 11.
    El-Serag, HB, Graham, DY, Satia, JA, Rabeneck, L 2005Obesity is an independent risk factor for GERD symptoms and erosive esophagitisAm J Gastroenterol100124350PubMedCrossRefGoogle Scholar
  12. 12.
    Nocon, M, Labenz, J, Willich, SN 2006Lifestyle factors and symptoms of gastro-oesophageal reflux—a population-based studyAliment Pharmacol Ther2316974PubMedCrossRefGoogle Scholar
  13. 13.
    Lagergren, J, Bergstrom, R, Nyren, O 2000No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based studyGut47269PubMedCrossRefGoogle Scholar
  14. 14.
    Fujiwara, Y, Higuchi, K, Shiba, M, Yamamori, K, Watanabe, Y, Sasaki, E,  et al. 2005Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in JapanAm J Gastroenterol1007548PubMedCrossRefGoogle Scholar
  15. 15.
    Labenz, J, Jaspersen, D, Kulig, M, Leodolter, A, Lind, T, Meyer-Sabellek, W,  et al. 2004Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiativeAm J Gastroenterol9916526PubMedCrossRefGoogle Scholar
  16. 16.
    van Oijen, MG, Josemanders, DF, Laheij, RJ, van Rossum, LG, Tan, AC, Jansen, JB 2006Gastrointestinal disorders and symptoms: does body mass index matter?Neth J Med64459PubMedGoogle Scholar
  17. 17.
    Lundell, L, Ruth, M, Sandberg, N, Bove-Nielsen, M 1995Does massive obesity promote abnormal gastroesophageal reflux?Dig Dis Sci4016325PubMedCrossRefGoogle Scholar
  18. 18.
    Nilsson, M, Johnsen, R, Ye, W, Hveem, K, Lagergren, J 2003Obesity and estrogen as risk factors for gastroesophageal reflux symptomsJAMA2906672PubMedCrossRefGoogle Scholar
  19. 19.
    Hampel, H, Abraham, NS, El-Serag, HB 2005Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complicationsAnn Intern Med143199211PubMedGoogle Scholar
  20. 20.
    Fraser-Moodie, CA, Norton, B, Gornall, C, Magnago, S, Weale, AR, Holmes, GK 1999Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweightScand J Gastroenterol3433740PubMedCrossRefGoogle Scholar
  21. 21.
    Wilson, LJ, Ma, W, Hirschowitz, BI 1999Association of obesity with hiatal hernia and esophagitisAm J Gastroenterol9428404PubMedCrossRefGoogle Scholar
  22. 22.
    Kjellin, A, Ramel, S, Rossner, S, Thor, K 1996Gastroesophageal reflux in obese patients is not reduced by weight reductionScand J Gastroenterol31104751PubMedGoogle Scholar
  23. 23.
    Cremonini, F, Locke, GR,3rd, Schleck, CD, Zinsmeister, AR, Talley, NJ 2006Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohortNeurogastroenterol Motil1898794PubMedCrossRefGoogle Scholar
  24. 24.
    El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases esophageal acid exposure. Gut 2006;24:[Epub ahead of print]Google Scholar
  25. 25.
    Devesa, SS, Blot, WJ, Fraumeni, JF,Jr 1998Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer83204953PubMedCrossRefGoogle Scholar
  26. 26.
    Blot, WJ, McLaughlin, JK 1999The changing epidemiology of esophageal cancerSemin Oncol2628PubMedGoogle Scholar
  27. 27.
    Botterweck, AA, Schouten, LJ, Volovics, A, Dorant, E, van Den Brandt, PA 2000Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countriesInt J Epidemiol2964554PubMedCrossRefGoogle Scholar
  28. 28.
    Chow, WH, Finkle, WD, McLaughlin, JK, Frankl, H, Ziel, HK, Fraumeni, JF,Jr 1995The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardiaJAMA2744747PubMedCrossRefGoogle Scholar
  29. 29.
    Lagergren, J, Bergstrom, R, Lindgren, A, Nyren, O 1999Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinomaN Engl J Med34082531PubMedCrossRefGoogle Scholar
  30. 30.
    Calle, EE, Rodriguez, C, Walker-Thurmond, K, Thun, MJ 2003Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adultsN Engl J Med348162538PubMedCrossRefGoogle Scholar
  31. 31.
    Brown, LM, Swanson, CA, Gridley, G, Swanson, GM, Schoen-berg, JB, Greenberg, RS,  et al. 1995Adenocarcinoma of the esophagus: role of obesity and dietJ Natl Cancer Inst871049PubMedCrossRefGoogle Scholar
  32. 32.
    Vaughan, TL, Davis, S, Kristal, A, Thomas, DB 1995Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinomaCancer Epidemiol Biomarkers Prev48592PubMedGoogle Scholar
  33. 33.
    Lagergren, J, Bergstrom, R, Nyren, O 1999Association between body mass and adenocarcinoma of the esophagus and gastric cardiaAnn Intern Med13088390PubMedGoogle Scholar
  34. 34.
    Veugelers, PJ, Porter, GA, Guernsey, L, Casson, AG 2006Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinomaDis Esophagus193218PubMedCrossRefGoogle Scholar
  35. 35.
    Jankowski, JA, Wright, NA, Meltzer, SJ, Triadafilopoulos, G, Geboes, K, Casson, AG,  et al. 1999Molecular evolution of the metaplasia–dysplasia–adenocarcinoma sequence in the esophagusAm J Pathol15496573PubMedGoogle Scholar
  36. 36.
    Eloubeidi, MA, Provenzale, D 2001Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veteransJ Clin Gastroenterol333069PubMedCrossRefGoogle Scholar
  37. 37.
    Conio, M, Filiberti, R, Blanchi, S, Ferraris, R, Marchi, S, Ravelli, P,  et al. 2002Risk factors for Barrett's esophagus: a case–control studyInt J Cancer972259PubMedCrossRefGoogle Scholar
  38. 38.
    Phillips, RW, Wong, RK 1991Barrett's esophagus. Natural history, incidence, etiology, and complicationsGastroenterol Clin North Am20791816PubMedGoogle Scholar
  39. 39.
    Winters, C,Jr, Spurling, TJ, Chobanian, SJ, Curtis, DJ, Esposito, RL, Hacker, JF,3rd,  et al. 1987Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux diseaseGastroenterology9211824PubMedGoogle Scholar
  40. 40.
    Drewitz, DJ, Sampliner, RE, Garewal, HS 1997The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 yearsAm J Gastroenterol922125PubMedGoogle Scholar
  41. 41.
    Miros, M, Kerlin, P, Walker, N 1991Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagusGut3214416PubMedGoogle Scholar
  42. 42.
    O'Connor, JB, Falk, GW, Richter, JE 1999The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus RegistryAm J Gastroenterol94203742PubMedGoogle Scholar
  43. 43.
    Anderson, LA, Murphy, SJ, Johnston, BT, Watson, P, Comber, H, Reynolds, JV,  et al. 2005Obesity and smoking in patients with Barrett's esophagus and esophageal adenocarcinoma: results from the Finbar studyGastroenterology128A4950Google Scholar
  44. 44.
    Gerson, LB, Shetler, K, Triadafilopoulos, G 2002Prevalence of Barrett's esophagus in asymptomatic individualsGastroenterology1234617PubMedCrossRefGoogle Scholar
  45. 45.
    Menke-Pluymers, MB, Schoute, NW, Mulder, AH, Hop, WC, van Blankenstein, M, Tilanus, HW 1992Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagusGut3314548PubMedGoogle Scholar
  46. 46.
    Wakelin, DE, Al-Mutawa, T, Wendel, C, Green, C, Garewal, HS, Fass, R 2003A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposureGastrointest Endosc583505PubMedCrossRefGoogle Scholar
  47. 47.
    Stein, DJ, El-Serag, HB, Kuczynski, J, Kramer, JR, Sampliner, RE 2005The association of body mass index with Barrett's oesophagusAliment Pharmacol Ther22100510PubMedCrossRefGoogle Scholar
  48. 48.
    Chak, A, Lee, T, Kinnard, MF, Brock, W, Faulx, A, Willis, J,  et al. 2002Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adultsGut513238PubMedCrossRefGoogle Scholar
  49. 49.
    Smith, KJ, O'Brien, SM, Smithers, BM, Gotley, DC, Webb, PM, Green, AC,  et al. 2005Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagusCancer Epidemiol Biomarkers Prev1424816PubMedCrossRefGoogle Scholar
  50. 50.
    El-Serag, HB, Kvapil, P, Hacken-Bitar, J, Kramer, JR 2005Abdominal obesity and the risk of Barrett's esophagusAm J Gastroenterol10021516PubMedCrossRefGoogle Scholar
  51. 51.
    Vaughan, TL, Kristal, AR, Blount, PL, Levine, DS, Galipeau, PC, Prevo, LJ,  et al. 2002Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagusCancer Epidemiol Biomarkers Prev1174552PubMedGoogle Scholar
  52. 52.
    Mittal, RK, Balaban, DH 1997The esophagogastric junctionN Engl J Med33692432PubMedCrossRefGoogle Scholar
  53. 53.
    Dent, J, Dodds, WJ, Friedman, RH, Sekiguchi, T, Hogan, WJ, Arndorfer, RC,  et al. 1980Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjectsJ Clin Invest6525667PubMedCrossRefGoogle Scholar
  54. 54.
    Kawanishi, M 2005Development of reflux esophagitis following Helicobacter pylori eradicationJ Gastroenterol4010248PubMedCrossRefGoogle Scholar
  55. 55.
    Patti, MG, Goldberg, HI, Arcerito, M, Bortolasi, L, Tong, J, Way, LW 1996Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injuryAm J Surg1711826PubMedCrossRefGoogle Scholar
  56. 56.
    Iwakiri, K, Sugiura, T, Hayashi, Y, Kotoyori, M, Kawakami, A, Makino, H,  et al. 2003Esophageal motility in Japanese patients with Barrett's esophagusJ Gastroenterol38103641PubMedCrossRefGoogle Scholar
  57. 57.
    McCallum, RW, Berkowitz, DM, Lerner, E 1981Gastric emptying in patients with gastroesophageal refluxGastroenterology8028591PubMedGoogle Scholar
  58. 58.
    Rourk, RM, Namiot, Z, Sarosiek, J, Yu, Z, McCallum, RW 1994Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitisAm J Gastroenterol8923744PubMedGoogle Scholar
  59. 59.
    Asaoka, D, Miwa, H, Hirai, S, Ohkawa, A, Kurosawa, A, Kawabe, M,  et al. 2005Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitisJ Gastroenterol4078190PubMedCrossRefGoogle Scholar
  60. 60.
    El-Serag, HB, Tran, T, Richardson, P, Ergun, G 2006Anthropometric correlates of intragastric pressureScand J Gastroenterol4188791PubMedCrossRefGoogle Scholar
  61. 61.
    Barak, N, Ehrenpreis, ED, Harrison, JR, Sitrin, MD 2002Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerationsObes Rev3915PubMedCrossRefGoogle Scholar
  62. 62.
    Jones, MP, Sloan, SS, Jovanovic, B, Kahrilas, PJ 2002Impaired egress rather than increased access: an important independent predictor of erosive oesophagitisNeurogastroenterol Motil1462531PubMedCrossRefGoogle Scholar
  63. 63.
    Jones, MP, Sloan, SS, Rabine, JC, Ebert, CC, Huang, CF, Kahrilas, PJ 2001Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux diseaseAm J Gastroenterol9617117PubMedCrossRefGoogle Scholar
  64. 64.
    John, BJ, Irukulla, S, Abulafi, AM, Kumar, D, Mendall, MA 2006Systematic review: adipose tissue, obesity and gastrointestinal diseasesAliment Pharmacol Ther23151123PubMedCrossRefGoogle Scholar
  65. 65.
    Considine, RV, Sinha, MK, Heiman, ML, Kriauciunas, A, Stephens, TW, Nyce, MR,  et al. 1996Serum immunoreactive-leptin concentrations in normal-weight and obese humansN Engl J Med3342925PubMedCrossRefGoogle Scholar
  66. 66.
    Ogunwobi, O, Mutungi, G, Beales, IL 2006Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activationEndocrinology147450516PubMedCrossRefGoogle Scholar
  67. 67.
    Blot, WJ, Devesa, SS, Kneller, RW, Fraumeni, JF,Jr 1991Rising incidence of adenocarcinoma of the esophagus and gastric cardiaJAMA26512879PubMedCrossRefGoogle Scholar
  68. 68.
    Chow, WH, Blot, WJ, Vaughan, TL, Risch, HA, Gammon, MD, Stanford, JL,  et al. 1998Body mass index and risk of adenocarcinomas of the esophagus and gastric cardiaJ Natl Cancer Inst901505PubMedCrossRefGoogle Scholar
  69. 69.
    Zhang, J, Su, XQ, Wu, XJ, Liu, YH, Wang, H, Zong, XN,  et al. 2003Effect of body mass index on adenocarcinoma of gastric cardiaWorld J Gastroenterol9265861PubMedGoogle Scholar
  70. 70.
    Kubo, A, Corley, DA 2006Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysisCancer Epidemiol Biomarkers Prev158728PubMedCrossRefGoogle Scholar
  71. 71.
    American Cancer Society2006Cancer facts and figuresAmerican Cancer SocietyNewYorkGoogle Scholar
  72. 72.
    Garland, C, Shekelle, RB, Barrett-Connor, E, Criqui, MH, Rossof, AH, Paul, O 1985Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in menLancet13079PubMedCrossRefGoogle Scholar
  73. 73.
    Giovannucci, E 2002Modifiable risk factors for colon cancerGastroenterol Clin North Am3192543PubMedCrossRefGoogle Scholar
  74. 74.
    Chute, CG, Willett, WC, Colditz, GA, Stampfer, MJ, Baron, JA, Rosner, B,  et al. 1991A prospective study of body mass, height, and smoking on the risk of colorectal cancer in womenCancer Causes Control211724PubMedCrossRefGoogle Scholar
  75. 75.
    Bostick, RM, Potter, JD, Kushi, LH, Sellers, TA, Steinmetz, KA, McKenzie, DR,  et al. 1994Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States)Cancer Causes Control53852PubMedCrossRefGoogle Scholar
  76. 76.
    Graham, S, Marshall, J, Haughey, B, Mittelman, A, Swanson, M, Zielezny, M,  et al. 1988Dietary epidemiology of cancer of the colon in western New YorkAm J Epidemiol128490503PubMedGoogle Scholar
  77. 77.
    Klatsky, AL, Armstrong, MA, Friedman, GD, Hiatt, RA 1988The relations of alcoholic beverage use to colon and rectal cancerAm J Epidemiol128100715PubMedGoogle Scholar
  78. 78.
    Giovannucci, E, Ascherio, A, Rimm, EB, Colditz, GA, Stampfer, MJ, Willett, WC 1995Physical activity, obesity, and risk for colon cancer and adenoma in menAnn Intern Med12232734PubMedGoogle Scholar
  79. 79.
    Schoen, RE, Tangen, CM, Kuller, LH, Burke, GL, Cushman, M, Tracy, RP,  et al. 1999Increased blood glucose and insulin, body size, and incident colorectal cancerJ Natl Cancer Inst91114754PubMedCrossRefGoogle Scholar
  80. 80.
    Must, A, Jacques, PF, Dallal, GE, Bajema, CJ, Dietz, WH 1992Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935N Engl J Med32713505PubMedCrossRefGoogle Scholar
  81. 81.
    Le Marchand, L, Wilkens, LR, Mi, MP 1992Obesity in youth and middle age and risk of colorectal cancer in menCancer Causes Control334954PubMedCrossRefGoogle Scholar
  82. 82.
    Limburg, PJ, Anderson, KE, Johnson, TW, Jacobs, DR,Jr, Lazovich, D, Hong, CP,  et al. 2005Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health StudyCancer Epidemiol Biomarkers Prev141337PubMedGoogle Scholar
  83. 83.
    Yoshida, I, Suzuki, A, Vallee, M, Matano, Y, Masunaga, T, Zenda, T,  et al. 2006Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colonClin Gastroenterol Hepatol4122531PubMedCrossRefGoogle Scholar
  84. 84.
    Saydah, SH, Platz, EA, Rifai, N, Pollak, MN, Brancati, FL, Helzlsouer, KJ 2003Association of markers of insulin and glucose control with subsequent colorectal cancer riskCancer Epidemiol Biomarkers Prev124128PubMedGoogle Scholar
  85. 85.
    Ehrmann-Josko, A, Sieminska, J, Gornicka, B, Ziarkiewicz-Wroblewska, B, Ziolkowski, B, Muszynski, J 2006Impaired glucose metabolism in colorectal cancerScand J Gastroenterol41107986PubMedCrossRefGoogle Scholar
  86. 86.
    McKeown-Eyssen, G 1994Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?Cancer Epidemiol Biomarkers Prev368795PubMedGoogle Scholar
  87. 87.
    Ahmed, RL, Schmitz, KH, Anderson, KE, Rosamond, WD, Folsom, AR 2006The metabolic syndrome and risk of incident colorectal cancerCancer1072836PubMedCrossRefGoogle Scholar
  88. 88.
    Wang, YY, Lin, SY, Lai, WA, Liu, PH, Sheu, WH 2005Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese populationJ Gastroenterol Hepatol2014105PubMedCrossRefGoogle Scholar
  89. 89.
    Watkins, LF, Lewis, LR, Levine, AE 1990Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell lineInt J Cancer453725PubMedCrossRefGoogle Scholar
  90. 90.
    Koenuma, M, Yamori, T, Tsuruo, T 1989Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26Jpn J Cancer Res80518PubMedGoogle Scholar
  91. 91.
    Bjork, J, Nilsson, J, Hultcrantz, R, Johansson, C 1993Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29Scand J Gastroenterol2887984PubMedGoogle Scholar
  92. 92.
    Kaaks, R, Lukanova, A 2001Energy balance and cancer: the role of insulin and insulin-like growth factor-IProc Nutr Soc6091106PubMedCrossRefGoogle Scholar
  93. 93.
    Aaronson, SA 1991Growth factors and cancerScience254114653PubMedCrossRefGoogle Scholar
  94. 94.
    Grau, MV, Rees, JR, Baron, JA 2006Chemoprevention in gastrointestinal cancers: current statusBasic Clin Pharmacol Toxicol982817PubMedCrossRefGoogle Scholar
  95. 95.
    Giovannucci, E, Rimm, EB, Stampfer, MJ, Colditz, GA, Ascherio, A, Willett, WC 1994Aspirin use and the risk for colorectal cancer and adenoma in male health professionalsAnn Intern Med1212416PubMedGoogle Scholar
  96. 96.
    Poullis, A, Foster, R, Shetty, A, Fagerhol, MK, Mendall, MA 2004Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer riskCancer Epidemiol Biomarkers Prev1327984PubMedCrossRefGoogle Scholar
  97. 97.
    Seril, DN, Liao, J, Yang, GY, Yang, CS 2003Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal modelsCarcinogenesis2435362PubMedCrossRefGoogle Scholar
  98. 98.
    Kadowaki, T, Hara, K, Yamauchi, T, Terauchi, Y, Tobe, K, Nagai, R 2003Molecular mechanism of insulin resistance and obesityExp Biol Med (Maywood)22811117Google Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Sumio Watanabe
    • 1
  • Mariko Hojo
    • 1
  • Akihito Nagahara
    • 1
  1. 1.Department of GastroenterologyJuntendo University, School of MedicineTokyoJapan

Personalised recommendations